Clinical trial
An Open Label Phase 1b Study of Felzartamab in Lupus Nephritis
NCT06064929 is registered in ClinicalTrials.gov with HI-Bio, A Biogen Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open Label Phase 1b Study of Felzartamab in Lupus Nephritis
- Lead sponsor
- HI-Bio, A Biogen Company
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 1, 2023
- Completion date
- July 8, 2026
- Enrollment
- 14 (actual)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.